Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 2
2006 2
2007 4
2009 1
2010 1
2011 3
2012 4
2013 3
2014 3
2015 5
2016 10
2017 8
2018 11
2019 14
2020 13
2021 6
2022 4
2023 12
2024 17
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for set are mansouri
Your search for Setare Mansouri retrieved no results
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Risk Factors Collaborators. GBD 2019 Risk Factors Collaborators. Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2. Lancet. 2020. PMID: 33069327 Free PMC article.
FINDINGS: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure. ...
FINDINGS: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and ec …
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
GBD 2021 Forecasting Collaborators. GBD 2021 Forecasting Collaborators. Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8. Lancet. 2024. PMID: 38762325 Free PMC article.
METHODS: Using forecasts of major drivers of health such as the Socio-demographic Index (SDI; a composite measure of lag-distributed income per capita, mean years of education, and total fertility under 25 years of age) and the full set of risk factor exposures captured by …
METHODS: Using forecasts of major drivers of health such as the Socio-demographic Index (SDI; a composite measure of lag-distributed income …
Five insights from the Global Burden of Disease Study 2019.
GBD 2019 Viewpoint Collaborators. GBD 2019 Viewpoint Collaborators. Lancet. 2020 Oct 17;396(10258):1135-1159. doi: 10.1016/S0140-6736(20)31404-5. Lancet. 2020. PMID: 33069324 Free PMC article. Review.
The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and ter …
The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on lev …
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Cancer Collaborators. GBD 2023 Cancer Collaborators. Lancet. 2025 Oct 11;406(10512):1565-1586. doi: 10.1016/S0140-6736(25)01635-6. Epub 2025 Sep 24. Lancet. 2025. PMID: 41015051 Free PMC article.
The decline in age-standardised mortality rates from cancer is encouraging but insufficient to meet the SDG target set for 2030. Effectively and sustainably addressing cancer burden globally will require comprehensive national and international efforts that consider health …
The decline in age-standardised mortality rates from cancer is encouraging but insufficient to meet the SDG target set for 2030. Effe …
Managing competing goals - a key role for the frontopolar cortex.
Mansouri FA, Koechlin E, Rosa MGP, Buckley MJ. Mansouri FA, et al. Nat Rev Neurosci. 2017 Nov;18(11):645-657. doi: 10.1038/nrn.2017.111. Epub 2017 Sep 29. Nat Rev Neurosci. 2017. PMID: 28951610 Review.
Humans are set apart from other animals by many elements of advanced cognition and behaviour, including language, judgement and reasoning. ...
Humans are set apart from other animals by many elements of advanced cognition and behaviour, including language, judgement and reaso …
CERAPP: Collaborative Estrogen Receptor Activity Prediction Project.
Mansouri K, Abdelaziz A, Rybacka A, Roncaglioni A, Tropsha A, Varnek A, Zakharov A, Worth A, Richard AM, Grulke CM, Trisciuzzi D, Fourches D, Horvath D, Benfenati E, Muratov E, Wedebye EB, Grisoni F, Mangiatordi GF, Incisivo GM, Hong H, Ng HW, Tetko IV, Balabin I, Kancherla J, Shen J, Burton J, Nicklaus M, Cassotti M, Nikolov NG, Nicolotti O, Andersson PL, Zang Q, Politi R, Beger RD, Todeschini R, Huang R, Farag S, Rosenberg SA, Slavov S, Hu X, Judson RS. Mansouri K, et al. Environ Health Perspect. 2016 Jul;124(7):1023-33. doi: 10.1289/ehp.1510267. Epub 2016 Feb 23. Environ Health Perspect. 2016. PMID: 26908244 Free PMC article.
METHODS: CERAPP combined multiple models developed in collaboration with 17 groups in the United States and Europe to predict ER activity of a common set of 32,464 chemical structures. Quantitative structure-activity relationship models and docking approaches were employed …
METHODS: CERAPP combined multiple models developed in collaboration with 17 groups in the United States and Europe to predict ER activity of …
Neuropelveology for Endometriosis Management: A Systematic Review and Multilevel Meta-Analysis.
Allahqoli L, Hakimi S, Momenimovahed Z, Mazidimoradi A, Rezaei F, Aghamohammadi SZ, Rahmani A, Mansouri G, Hadavandsiri F, Salehiniya H, Alkatout I. Allahqoli L, et al. J Clin Med. 2024 Aug 9;13(16):4676. doi: 10.3390/jcm13164676. J Clin Med. 2024. PMID: 39200818 Free PMC article. Review.
The search was conducted in January 2024 with no date or language restrictions using a carefully curated set of keywords. We conducted a comprehensive review, including all observational and clinical trials reporting data on neuropelveology approaches in the management of …
The search was conducted in January 2024 with no date or language restrictions using a carefully curated set of keywords. We conducte …
Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM.
Pearlman AH, Wang Y, Kalluri A, Parker M, Cohen JD, Dudley J, Rincon-Torroella J, Xia Y, Gensler R, Alfonzo Horowitz M, Theodore JN, Dobbyn L, Popoli M, Ptak J, Silliman N, Judge K, Calabresi PA, Groves M, Jackson CM, Jackson EM, Jallo GI, Lim M, Luciano M, Mukherjee D, Naidoo J, Rozati S, Sterling CH, Weingart J, Koschmann C, Mansouri A, Glantz M, Kamson D, Schreck KC, Pardo CA, Holdhoff M, Konig MF, Paul S, Kinzler KW, Papadopoulos N, Vogelstein B, Douville C, Bettegowda C. Pearlman AH, et al. Cancer Discov. 2025 Oct 6;15(10):2002-2018. doi: 10.1158/2159-8290.CD-24-1788. Cancer Discov. 2025. PMID: 40854146 Free PMC article.
In this study, we present a new workflow termed "CSF-BAM" that simultaneously identifies B-cell or T-cell receptor sequences, aneuploidy, and mutations using amplification of both strands of the DNA from cerebrospinal fluid (CSF) samples. We applied CSF-BAM to a validation set …
In this study, we present a new workflow termed "CSF-BAM" that simultaneously identifies B-cell or T-cell receptor sequences, aneuploidy, an …
Detection of human brain cancers using genomic and immune cell characterization of cerebrospinal fluid through CSF-BAM.
Pearlman AH, Wang Y, Kalluri A, Parker M, Cohen JD, Dudley J, Rincon-Torroella J, Xia Y, Gensler R, Alfonzo Horwitz M, Theodore J, Dobbyn L, Popoli M, Ptak J, Silliman N, Judge K, Groves M, Jackson CM, Jackson EM, Jallo GI, Lim M, Luciano M, Mukherjee D, Naidoo J, Rozati S, Sterling CH, Weingart J, Koschmann C, Mansouri A, Glantz M, Kamson D, Schreck KC, Pardo CA, Holdhoff M, Paul S, Kinzler KW, Papadopoulos N, Vogelstein B, Douville C, Bettegowda C. Pearlman AH, et al. medRxiv [Preprint]. 2025 Feb 12:2024.12.02.24318303. doi: 10.1101/2024.12.02.24318303. medRxiv. 2025. Update in: Cancer Discov. 2025 Oct 6;15(10):2002-2018. doi: 10.1158/2159-8290.CD-24-1788. PMID: 39677487 Free PMC article. Updated. Preprint.
We then applied CSF-BAM to an independent set of 206 DNA samples from patients with common, aggressive cancer types as well as other forms of brain cancers. ...
We then applied CSF-BAM to an independent set of 206 DNA samples from patients with common, aggressive cancer types as well as other …
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review.
Millward CP, Keshwara SM, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Dirven L, Grundy PL, Islim AI, Javadpour M, Koszdin SD, Marson AG, McDermott MW, Meling TR, Oliver K, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Turner C, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD; EORTC BTG, ICOM, EANO, SNO, RANO-PRO, BNOS, SBNS, BIMS, TBTC, International Brain Tumour Alliance, Brainstrust, and Brain Tumour Foundation of Canada. Millward CP, et al. Neurooncol Adv. 2024 Mar 2;6(1):vdae030. doi: 10.1093/noajnl/vdae030. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38596717 Free PMC article.
The standardized outcome terms identified will be prioritized through an eDelphi survey and consensus meeting of key stakeholders (including patients), in order to develop a core outcome set for use in future meningioma clinical trials....
The standardized outcome terms identified will be prioritized through an eDelphi survey and consensus meeting of key stakeholders (including …
132 results